Where to Get Compounded Tirzepatide: How to Evaluate a Pharmacy and Telehealth Provider

Important Disclaimer: Compounded tirzepatide is NOT FDA-approved. The FDA does not review or verify the safety, effectiveness, or quality of compounded medications. Compounded tirzepatide has NOT undergone bioequivalence testing and has NOT been shown to be equivalent in safety or effectiveness to the FDA-approved products Mounjaro or Zepbound. This article is educational only. It is not medical or legal advice. Talk with a licensed healthcare provider about whether any treatment, including FDA-approved options, is right for you.

If you have searched “where to get compounded tirzepatide,” you have probably found a long list of websites promising fast, cheap, no-hassle access. That is the wrong question to start with. A better question is: how do I tell a legitimate, well-run source from a risky one? Compounded tirzepatide is not a commodity you should buy from whoever ranks first or charges least. The quality, oversight, and legitimacy of the pharmacy and the prescribing clinician matter more than the headline.

This guide is a vetting checklist, not a buying guide. It walks through the questions to ask, the standards to look for, and the warning signs that should make you walk away — so that if you and a licensed clinician decide compounded tirzepatide is appropriate, you can evaluate any source on the merits.

Boxed Warning — Thyroid C-Cell Tumors. The FDA-approved tirzepatide products (Mounjaro and Zepbound) carry a Boxed Warning regarding the risk of thyroid C-cell tumors. In rodent studies, tirzepatide caused thyroid C-cell tumors; it is not known whether it causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Tirzepatide is contraindicated in people with a personal or family history of MTC and in people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Because compounded tirzepatide is the same molecule, the same risk and contraindications should be observed. Tell your clinician about your medical and family history before starting any tirzepatide product.

Reframe the Question: Vetting, Not Shopping

“Where can I buy this fastest and cheapest” optimizes for the wrong outcome. Tirzepatide is an injectable prescription medication, and a compounded version is a non-FDA-reviewed preparation made by a pharmacy. The variables that actually affect your safety are not price or speed — they are who made it, how, under what license, and with what clinical oversight.

So instead of ranking sellers, evaluate any candidate source against a consistent set of criteria. A source either meets the bar or it doesn’t. The sections below are those criteria, in roughly the order of importance. If a source fails the early ones (licensing, oversight, honest claims), nothing later in the list can rescue it.

Criterion 1: State Licensing and Pharmacy Legitimacy

The single most important question is whether the medication comes from a pharmacy that is licensed by a state board of pharmacy and in good standing. Compounded medications must be prepared by licensed compounding pharmacies based on a valid prescription. A legitimate source will tell you which pharmacy dispenses the medication and in which state it is licensed.

You can generally verify a pharmacy’s license through the relevant state board of pharmacy and check disciplinary history. The National Association of Boards of Pharmacy maintains resources for verifying pharmacies (Source: NABP). If a website will not name the pharmacy, will not say where it is licensed, or ships from an unverifiable overseas source, that is a foundational failure — not a detail to overlook.

Licensing also implies accountability. A state-licensed pharmacy answers to a regulator, must follow pharmacy law, and can face warning letters, recalls, or discipline that are part of the public record. An anonymous seller answers to no one.

Criterion 2: 503A Compounding Pharmacies — Know Who You’re Dealing With

Compounded medications must be prepared by state-licensed 503A compounding pharmacies pursuant to a valid patient-specific prescription (Source: FDA). State-licensed 503A compounding pharmacies are regulated primarily by state boards of pharmacy; they prepare medications for individual patients based on patient-specific prescriptions — the preparation is made for that patient pursuant to a clinician’s order. The medications they prepare are not FDA-approved, regardless of how well-run the pharmacy is.

A legitimate source can identify which pharmacy dispenses the medication and in which state it is licensed. An evasive one cannot.

Criterion 3: “FDA-Registered” Is Not “FDA-Approved”

This is the most common point of confusion that marketing exploits. You will see phrases like “made in an FDA-registered facility” or “FDA-registered ingredients.” Registration means a facility has listed itself with the FDA or that an ingredient supplier is registered. Registration is NOT FDA approval of the medication. The FDA has not reviewed the compounded tirzepatide product for safety, effectiveness, or quality, regardless of where it was made.

Treat “FDA-registered” as a neutral fact about a facility, not as a quality endorsement of the drug. If a seller leans on “FDA-registered” to imply the product is FDA-approved or equivalent to Zepbound or Mounjaro, that is misleading — and a reason to be skeptical of everything else they claim.

Criterion 4: Third-Party Testing and Certificates of Analysis

A serious source can document that the medication was tested. For sterile injectables, that generally means testing for potency (is the dose what the label says), sterility, and endotoxins, often performed or confirmed by an independent third-party laboratory. The document summarizing these results is a Certificate of Analysis (COA).

You should be able to ask for, and receive, information about testing. Reasonable things to look for:

• Whether the API (active ingredient) comes with a supplier COA
• Whether finished-product or batch testing is performed
• Whether testing is done by an independent, third-party lab
• Whether the pharmacy will provide documentation on request

A source that cannot or will not document testing is asking you to take potency and sterility on faith. For an injectable, that is not a reasonable thing to take on faith.

Criterion 5: USP Standards and Sterile Compounding

The U.S. Pharmacopeia (USP) publishes standards for compounding. The most relevant for an injectable like tirzepatide is USP <797>, which governs sterile compounding — the cleanroom conditions, aseptic technique, and beyond-use dating that reduce contamination risk. USP <795> covers non-sterile compounding. A legitimate compounding pharmacy prepares sterile injectables in compliance with USP <797>.

You do not need to become a USP expert. You do need a source that can confirm it follows USP <797> for sterile preparation and assigns appropriate beyond-use dates. Sterility is not optional for something you inject. Vague answers here are disqualifying.

Criterion 6: Real Clinician Oversight

Compounded tirzepatide must be prescribed. A legitimate source involves a licensed healthcare provider who evaluates whether the medication is appropriate for you, reviews your history, and is available for follow-up and monitoring. This is not a formality — tirzepatide has contraindications and side effects, and dosing should be individualized and supervised, never self-directed.

Red flag territory: any source that sells the medication without a genuine clinical evaluation, lets you skip an intake, “rubber-stamps” prescriptions, or markets “no consultation needed.” If you can add an injectable prescription medication to a cart and check out like a t-shirt, that is a sign the clinical oversight is missing or fake. For background on how tirzepatide is administered under clinician guidance, see our tirzepatide injection guide.

Criterion 7: Transparency and Honest Claims

How a source talks about its product tells you a lot about how it operates. Honest providers state plainly that compounded tirzepatide is not FDA-approved and is not the same as Zepbound or Mounjaro. They do not promise specific results, “guaranteed” weight loss, or a defined number of pounds. They explain what they can document and what they cannot.

Dishonest claims are themselves a red flag. If a seller implies the product is “the same as” the brand, claims it is “FDA-approved,” guarantees outcomes, or sells material labeled “research use only” / “not for human consumption” while winking that you can inject it anyway, walk away. “Research use only” products are not made or sold for medical use, and using them as medication is dangerous and outside any legitimate clinical framework.

The Honest Compound Checklist: Green Flags vs Red Flags

Use this side-by-side checklist when evaluating any source. A source should clear the green-flag column and trip none of the red flags.

✅ Green Flags (look for these)	❌ Red Flags (walk away)
Names a state-licensed pharmacy you can verify	Won’t name the pharmacy or its state of licensure
Clearly states it is a state-licensed 503A compounding pharmacy	Can’t or won’t name the type of facility or its state license
States compounded tirzepatide is not FDA-approved	Implies it’s “FDA-approved” or “the same as” Zepbound/Mounjaro
Can provide testing info / COA on request	Can’t document potency, sterility, or testing
Follows USP <797> for sterile preparation	Vague or evasive about sterility standards
Requires a real clinical evaluation by a licensed provider	Sells without a clinician evaluation or “no consult needed”
Makes no outcome guarantees; sets realistic expectations	Promises guaranteed results or specific pounds lost
Offers ongoing support and monitoring	Sells “research use only” material for human use

Questions to Ask Before You Commit

If a source passes the checklist, confirm it directly. A legitimate provider will answer these without hesitation:

• Which pharmacy dispenses the medication, and in which state is it licensed?
• Is it a state-licensed 503A compounding pharmacy, and in which state is it licensed?
• Where does the active ingredient come from, and is there a supplier COA?
• What testing is done on the finished product, and can I see documentation?
• Do you follow USP <797>, and what beyond-use date applies to my vial?
• Will a licensed clinician evaluate me, and can I reach someone for follow-up?
• What do you tell patients about how this differs from Zepbound and Mounjaro?

Note what is not on this list: price. Cost is a real consideration, but it is not a safety or legitimacy test. For current pricing, see the relevant product page rather than choosing a source on price alone. For broader context on compounded GLP-1 quality and regulation, see our guide to compounded semaglutide safety, which covers the same regulatory framework in depth.

Where Contour Health Stands

To be transparent about our own model, here are the facts. Contour Health’s compounded tirzepatide program is clinician-gated: a licensed healthcare provider evaluates whether the medication is appropriate before anything is prescribed. The medication is dispensed by U.S. state-licensed pharmacy partners coordinated through WellSync, our pharmacy and fulfillment partner, and is prepared as a patient-specific compounded preparation.

We state plainly that compounded tirzepatide is not FDA-approved and has not been shown to be equivalent to Zepbound or Mounjaro. We do not guarantee outcomes. For current pricing, please see the product page. You can also explore our broader weight loss treatment options. We share this not as a claim to be the only or best choice, but so you can apply the same checklist above to us as you would to anyone else.

Frequently Asked Questions

Is compounded tirzepatide the same as Zepbound or Mounjaro?

No. Compounded tirzepatide is not FDA-approved and has not undergone bioequivalence testing, so it has not been shown to be equivalent in safety or effectiveness to the FDA-approved products Zepbound or Mounjaro. The active molecule may be the same, but a compounded product is a different, non-FDA-reviewed preparation. Any source claiming they are “the same” is misleading you.

Does “FDA-registered facility” mean the medication is FDA-approved?

No. Facility registration means a facility has listed itself with the FDA; it is not FDA approval of the medication. The FDA has not reviewed compounded tirzepatide for safety, effectiveness, or quality regardless of where it is made. Treat “FDA-registered” as a neutral fact, not a quality endorsement of the drug.

How do I verify that a pharmacy is legitimate?

Ask which pharmacy dispenses the medication and in which state it is licensed, then verify the license and any disciplinary history through that state’s board of pharmacy. The National Association of Boards of Pharmacy also offers verification resources. A source that won’t name its pharmacy or state of licensure should be avoided.

Should I buy from the cheapest source I can find?

Price is not a safety or legitimacy test. An unusually low price can be a reason to ask more questions, not a reason to buy. Focus on licensing, clinician oversight, testing, and honest claims first. Compare pricing only among sources that already clear the safety bar, and check the product page for current pricing.

What if a site sells tirzepatide without requiring a consultation?

That is a serious red flag. Compounded tirzepatide is a prescription medication and should only be provided after a licensed clinician evaluates whether it is appropriate for you. “No consultation needed” or self-serve checkout for an injectable suggests the clinical oversight is missing. Avoid these sources.

What is “research use only” tirzepatide, and is it safe to use?

“Research use only” or “not for human consumption” products are not made or sold for medical use and are not prepared under the standards that apply to medications. Using them as a medication is dangerous and outside any legitimate clinical framework. Do not use research-use-only material as a treatment.

---

Related Articles

• Is Compounded Semaglutide Safe?
• Tirzepatide Injection Guide
• Complete Guide to Semaglutide

---

Medical Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. Compounded medications are not FDA-approved and should only be used under the supervision of a licensed healthcare provider. Individual safety and effectiveness may vary, and reports of patient experience are anecdotal. Always verify the quality and source of any compounded medication, and discuss FDA-approved options with your clinician before starting treatment.

Regulatory Disclaimer: Compounded tirzepatide is not FDA-approved. The FDA does not review or verify the safety, quality, or effectiveness of compounded drugs. Compounded tirzepatide has not undergone bioequivalence testing and has not been demonstrated to be equivalent to Zepbound or Mounjaro. Facility registration is not the same as FDA approval of the medication. Information about FDA regulations is current as of publication date and subject to change.